HIV Diagnostics Market is Gaining Rapid Traction with Roche Diagnostics receiving the U.S. FDA approval for its cobas HIV-1/HIV-2 Qualitative Test on the fully automated cobas 6800/8800 Systems in the U.S.

 


HIV diagnostics are not as simple to acquire as they may appear to be, and it's important that you get the correct tests for your particular condition. One shouldn't be embarrassed or feel ashamed about getting tested for the disease; after all, there are a lot of people who are living with HIV or AIDS and are leading happy lives. The reason you're being tested is simply so you can get the proper medical help you need, which can help you combat this dangerous disease.

Growing prevalence of HIV/AIDS is expected to drive growth of the global HIV diagnostics market. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2019, 38 million people were living with HIV across the globe, of which 36.2 million were adults and 1.8 million were children aged 15 years and below. According to the same source, around 1.7 million people across the globe acquired HIV in 2019. Such increasing prevalence has led to high demand for advanced HIV diagnostics devices and testing kits across the globe. Hence, such factors are expected to drive growth of the global HIV diagnostics market. Increasing proactive initiatives to create awareness regarding HIV/AIDS is expected to propel the global HIV diagnostics market growth in the near future. For instance, in December 2020, Manforce Condom, a product of Mankind Pharma, launched a new campaign titled “#StandTogether” to raise awareness regarding HIV. 

Lack of mandates for the nucleic acid test (NAT) and high costs associated with it in emerging economies is expected to restrain growth of the global HIB diagnostics market. Among regions, North America is expected to witness significant growth in the global HIV diagnostics market. This is owing to the presence of a technologically advanced healthcare network and higher expenditure in R&D. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to the presence of high unmet demand in China and India.

Major companies involved in the global HIV diagnostics market are Alere Inc., Qiagen, Abbott Healthcare, Siemens Healthcare, Abbvie Inc., Roche Diagnostics, Bristol-Myers Squibb, Mylan Inc., Janssen Therapeutics, Zyomyx Inc., Gilead Sciences, PointCare Technologies Inc., Merck & Co. Inc., Apogee Flow Systems, VIIV Healthcare, Sysmex, BD Biosciences, Partec, and Beckman Coulter.

For instance, in September 2020, Roche Diagnostics received the U.S. Food and Drug Administration (FDA) approval for its cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the U.S.


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers aroun...
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 ...
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 ne...
Read more